Adenocarcinoma: all 1,996 studies

Page 20 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.

• Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic AdenocarcinomaCompletedNCT00327327Phase 1
• Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaCompletedNCT00323830Phase 3
• A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic IrradiationTerminatedNCT00285415Phase 2
• Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1
• Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma MetastasesCompletedNCT00265356Phase 3
• Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The EsophagusCompletedNCT00259987Phase 2
• Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic CancerWithdrawnNCT00253526Phase 2
• Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.WithdrawnNCT00247936Not applicable
• High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate CancerCompletedNCT00243321Not applicable
• S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00238212Phase 2
• PTK787 in Patients With Advanced Metastatic Pancreatic AdenocarcinomaCompletedNCT00226005Phase 2
• Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNCT00220649Phase 1
• Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNCT00220103Phase 2
• Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.TerminatedNCT00216008Phase 2
• Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00215514Early Phase 1
• Vinorelbine in Unresectable or Metastatic Esophageal and Gastric AdenocarcinomaCompletedNCT00215462Phase 2
• Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric AdenocarcinomaTerminatedNCT00209079Phase 2
• Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal AdenocarcinomaTerminatedNCT00207831Phase 3
• Treatment of Lung Adenocarcinoma With Bronchioloalveolar FeatureCompletedNCT00198380Phase 2
• Gemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaCompletedNCT00191503Phase 2
• Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.CompletedNCT00183924Phase 2
• Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric AdenocarcinomaCompletedNCT00183911Phase 2
• Clinical and Pharmacokinetic Trial of Intra-Abdominal IrinotecanCompletedNCT00183859Phase 1
• Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal AdenocarcinomaCompletedNCT00168155Phase 2
• Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
• Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or EsophagusCompletedNCT00165191Phase 2
• A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal SurfacesCompletedNCT00162110Phase 2
• Phase I/II Trial GOFL in Advanced Pancreatic AdenocarcinomaCompletedNCT00154791Phase 1/2
• Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the ProstateCompletedNCT00151073Phase 2
• Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the ProstateCompletedNCT00151060Phase 2
• A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of RectumCompletedNCT00145769Phase 3
• Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompletedNCT00142480Phase 2
• Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast CancerCompletedNCT00140075Phase 3
• A Long Term Safety Study With AtrasentanCompletedNCT00127478Phase 2/3
• VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC FeaturesTerminatedNCT00117351Phase 2
• Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasTerminatedNCT00116389Phase 2
• S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach CancerCompletedNCT00103324Phase 2
• ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerCompletedNCT00102700Phase 2
• Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal AdenocarcinomaTerminatedNCT00102024Phase 1/2
• RAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaCompletedNCT00101972Phase 1
• FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT00098527Phase 2
• A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal AdenocarcinomaCompletedNCT00097578
• Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00085371Phase 2
• Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)CompletedNCT00085358Phase 1
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the ColonCompletedNCT00085163Phase 3
• Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00084604Phase 2
• Study of MDX-010 in Stage IV Breast CancerCompletedNCT00083278Phase 2
• Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the RectumTerminatedNCT00081224Phase 2
• DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal AdenocarcinomaCompletedNCT00080834Phase 2
• Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00079430Phase 1
• Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the PancreasStatus unknownNCT00079365Not applicable
• 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionCompletedNCT00077545Phase 2
• FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or RectumTerminatedNCT00077233Phase 3
• Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal AdenocarcinomaStatus unknownNCT00075556Phase 2
• Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the StomachStatus unknownNCT00075465Phase 2
• Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction AdenocarcinomaCompletedNCT00074009Phase 2
• Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) CancerCompletedNCT00073502Phase 2
• S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
• Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal CancerTerminatedNCT00070122Phase 3
• Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00061958Phase 2
• Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate AdenocarcinomaCompletedNCT00061035Phase 1
• A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
• Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerCompletedNCT00054873Phase 2
• Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00052689Phase 2
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNCT00052585Phase 2
• Phase I Study of a Monoclonal Antibody for Treatment of Advanced AdenocarcinomasCompletedNCT00051675Phase 1
• Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00045526Phase 2
• Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of PancreasTerminatedNCT00038701Phase 2
• Intravenous Estramustine With Taxol in Hormone Refractory Prostate AdenocarcinomaCompletedNCT00038168Phase 1/2
• Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal AdenocarcinomaCompletedNCT00034190Phase 2
• Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00032110Phase 2
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
• Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00026234Phase 2
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerWithdrawnNCT00025532Phase 1
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedCompletedNCT00025337Phase 3
• Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasCompletedNCT00020345Phase 2
• Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedNCT00019695Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerStatus unknownNCT00010270Phase 1
• Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerCompletedNCT00006387Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005840Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005830Phase 1
• SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005818Phase 1/2
• Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)TerminatedNCT00005039Phase 2
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
• Gene Therapy in Treating Patients With CancerCompletedNCT00004178Phase 1
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00003873Phase 3
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003834Phase 2
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00003799Phase 1
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerWithdrawnNCT00003517Phase 2
• Antineoplaston Therapy in Treating Patients With Colon CancerWithdrawnNCT00003486Phase 2
• Irinotecan in Treating Patients With Advanced Cancer of the StomachCompletedNCT00003137Phase 2
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
• Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedNCT00002796Phase 1/2
• Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the UterusCompletedNCT00002706Phase 3
• A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the ProstateCompletedNCT00001382Phase 1

← Adenocarcinoma overview